Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, December 4, 2017
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
[ Mon, Dec 04th 2017
] - WOPRAI
Fri, December 1, 2017
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
[ Fri, Dec 01st 2017
] - WOPRAI
Thu, November 30, 2017
[ Thu, Nov 30th 2017
] - WOPRAI
[ Thu, Nov 30th 2017
] - WOPRAI
[ Thu, Nov 30th 2017
] - WOPRAI
Jason McCarthy Maintained (BLUE) at Strong Buy with Increased Target to $200 on, Nov 30th, 2017
Jason McCarthy of Maxim Group, Maintained "bluebird bio, Inc." (BLUE) at Strong Buy with Increased Target from $170 to $200 on, Nov 30th, 2017.
Jason has made no other calls on BLUE in the last 4 months.
There are 6 other peers that have a rating on BLUE. Out of the 6 peers that are also analyzing BLUE, 3 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, November 6th, 2017
- Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, November 3rd, 2017
- Biren Amin of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, October 11th, 2017
These are the ratings of the 3 analyists that currently disagree with Jason
- Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
- Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017
